Rodenstock Spectacle Lenses for Myopia Control in Children
Myopia control spectacle lens
+ Single-vision lens
Eye Diseases
+ Myopia
+ Refractive Errors
Prevention Study
Summary
Study start date: July 22, 2025
Actual date on which the first participant was enrolled.Myopia, or nearsightedness, is a common vision problem in Singapore, especially among children and young adults. By the time children reach the sixth grade, a significant number of them are already myopic. This condition can lead to more serious eye problems in adulthood, such as cataracts and glaucoma. This study aims to test whether special spectacle lenses can slow down the worsening of myopia in children aged 6 to 12 years. By addressing myopia progression early, the study hopes to reduce the risk of future eye disorders and improve visual comfort and performance. In this study, 185 children with mild or moderate myopia will be randomly assigned to two groups. One group will wear regular single vision lenses, while the other group will wear myopia control lenses. After one year, those in the regular lens group will switch to the myopia control lenses. This crossover design helps to evaluate the effectiveness of the lenses in controlling myopia progression. The study will monitor changes in vision over two years to see how well the lenses work in slowing down myopia. Participants will have their eyesight checked regularly to assess any improvements or changes in their vision.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.185 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Prevention Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 6 to 12 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalGroup II
Active ComparatorStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location